G Michael Hass

Title: G Michael Hass: Innovator in Immunoassay Technology

Introduction

G Michael Hass is a notable inventor based in Libertyville, IL (US). He has made significant contributions to the field of immunoassay technology, particularly in the detection of immunoglobulin IgA1. His innovative approach has the potential to enhance diagnostic methods in medical laboratories.

Latest Patents

G Michael Hass holds a patent for the invention titled "Detection of altered IGA1 in fluid samples." This novel immunoassay method is designed for the detection of the immunoglobulin IgA1 with O-linked oligosaccharides lacking sialic acid in fluid samples, such as blood, serum, and plasma. The method involves extracting total IgA from fluid samples through a reaction with an immobilized anti-IgA antibody, followed by the detection of only the IgA1 fraction using labeled peanut agglutinin. This advancement could lead to improved diagnostic accuracy and patient outcomes.

Career Highlights

G Michael Hass is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to collaborate with other talented professionals in the field, contributing to the advancement of medical diagnostics.

Collaborations

Some of his notable coworkers include Jerry G Henslee and Jay R Schenck. Their collective expertise has fostered an environment of innovation and collaboration, further enhancing the impact of their work in immunoassay technology.

Conclusion

G Michael Hass is a distinguished inventor whose work in immunoassay technology is paving the way for advancements in medical diagnostics. His patent for detecting altered IgA1 demonstrates his commitment to improving healthcare solutions.